Cargando…
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins
Idiotype (Id)-based immunotherapy has been exploited as cancer treatment option. Conceived as therapy for malignancies bearing idiotypic antigens, it has been also extended to solid tumors because of the capacity of anti-idiotypic antibodies to mimic Id-unrelated antigens. In both these two settings...
Autores principales: | López-Requena, Alejandro, Burrone, Oscar R., Cesco-Gaspere, Michela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493989/ https://www.ncbi.nlm.nih.gov/pubmed/23162790 http://dx.doi.org/10.3389/fonc.2012.00159 |
Ejemplares similares
-
QUANTITATIVE INVESTIGATIONS OF IDIOTYPIC ANTIBODIES : VI. IDIOTYPIC SPECIFICITY AS A POTENTIAL GENETIC MARKER FOR THE VARIABLE REGIONS OF MOUSE IMMUNOGLOBULIN POLYPEPTIDE CHAINS
por: Kuettner, Mirta Goffan, et al.
Publicado: (1972) -
Antibodies to idiotypes of isologous immunoglobulins
Publicado: (1975) -
Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
por: Gress, Kyle, et al.
Publicado: (2020) -
The promise of the anti-idiotype concept
por: Kieber-Emmons, Thomas, et al.
Publicado: (2012) -
The Promise of Anti-idiotype Revisited
por: Kohler, Heinz, et al.
Publicado: (2019)